Accept Cookies?
Print Page | Contact Us | Report Abuse | Sign In | Join Us
Bio/ Angela Brand
Share |

Task Force 2 leader
Citizen-controlled Data governance and Data Donors

 

Angela BRAND

MD, PhD, MPH
Professor at the University of Maastricht                      

   

 

Professor Angela Brand is Full Professor in the Department of International Health at the Faculty of Health, Medicine and Life Sciences (FHML) as well as Professorial Fellow at UNU-MERIT (United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology) at Maastricht University, The Netherlands. She is also Director of the European Centre for Public Health Genomics (ECPHG) as well as Dr. T.M.A. Pai Endowment Chair on Public Health Genomics and Adjunct Professor at the School of Life Sciences at Manipal University, India. Before she worked in the clinics, at various academic institutions and in governmental bodies in the USA and Germany. She is Paediatrician, Specialist in Public Health Medicine, holds a PhD in pathology, a Master of Public Health (MPH) from Johns Hopkins University, USA, and received her habilitation focusing on Health Technology Assessment. She has been the pioneer of Public Health Genomics in Europe and coordinated and established successfully this field in more than 15 EU Member States within the last years (PHGEN, www.phgen.eu). She is Fellow of the Rockefeller Foundation, USA, of the 21st Century Trust of the Wellcome Trust, UK, and Member of the New York Academy of Sciences.

Professor Brand is Editor-in Chief of the international Journal Public Health Genomics. For the Estonian Presidency of the Council of the European Union she is leading Task Force 2 “Data Donors and Citizen-Controlled Data Governance” to prepare for the Digital Health Society.

Currently she is also Expert on „Big Data“ of the International Consortium Personalised Medicine (IC PerMed) jointly coordinated by the European Commission, over 26 European Member States and Canada. She serves as Expert for the European Medicines Agency (EMA), the OECD, WHO, the EC, the German Robert Koch-Institut (RKI), Genome Canada, Science Europe, AXA Research among others. She collaborates with industry partners such as IBM, Roche, Pfizer, AMGEN, Novartis, MSD, Bayer HealthCare. Her research focus is on Public Health Genomics, Personalised Medicine, Big Data Analytics for Public Health, PPP, Data Cooperatives and Innovation Management.

 

 

Back to Task Force 2's page

More information on the Digital Health Society